Medicinal and biological preparations for pharmaceutical, clinical and medical treatment, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and degradation processes related thereto for the treatment of cardiovascular diseases, metabolic diseases, overweight, obesity, diabetes mellitus, dyslipidemia, liver steatosis, steatohepatitis, non-alcoholic fatty liver disease, metabolic-associated fatty liver disease, atherosclerosis, chronic visceral inflammation, ovarian cancer and related diseases and disorders.

'alcohol':50 'associ':56 'atherosclerosi':60 'biolog':3 'cancer':65 'cardiovascular':36 'chronic':61 'clinic':7 'degrad':28 'diabet':42 'diseas':37,39,53,59,68 'disord':70 'dna':23 'dyslipidemia':44 'express':20 'fatti':51,57 'gene':17 'inflamm':63 'liver':45,52,58 'medic':9 'medicin':1 'mellitus':43 'metabol':38,55 'metabolic-associ':54 'modul':15 'name':11 'non':49 'non-alcohol':48 'obes':41 'ovarian':64 'overweight':40 'pharmaceut':6 'prepar':4,12 'process':29 'protein':19 'relat':30,67 'rna':25 'steatohepat':47 'steatosi':46 'thereto':31 'transcript':24 'translat':26 'treatment':10,34 'viscer':62 'work':21

APTAMIR

Owners

Goods & Services